Articles

  • Feb 1, 2024 | themarketherald.com.au | Bianca Gimondo

    PlaySide Studios (ASX:PLY) signs a new game to its publishing division called MOUSE, which is being developed by Fumi Games for PC and Console devices. MOUSE is a classic-style first-person retro-looking shooter game inspired by 1930s cartoons.

  • Feb 1, 2024 | themarketherald.com.au | Bianca Gimondo

    Carnaby Resources (ASX:CNB) hits a fresh vein of high-grade copper at its Greater Duchess project in Mt Isa, Queensland Exploration at the company’s Duchess Central Lode prospect returned a four-metre segment at seven per cent copper and 0.05 g/t gold CNB MD Rob Watkins expressed excitement about the proximity of the new high-grade intercept to the historically high-grade Duchess Mine Lode Plans are afoot for a major drilling program to commence soon Shares are up 3.91 per cent, trading at...

  • Jan 31, 2024 | themarketherald.com.au | Bianca Gimondo

    Brazilian Rare Earths (ASX:BRE) unveils ultra high-grade assay results, reaching up to 34.4 per cent TREO from maiden diamond drilling at its Monte Alto project The results expand the Monte Alto high-grade REE-Nb-Sc exploration corridor, which is open along strike and at depth The exploration target zone for REE-Nb-Sc mineralisation is below Monte Alto’s existing high-grade monazite sand deposit Meanwhile, BRE recently commenced a diamond drill program at its Velinhas target, seven kilometres...

  • Jan 31, 2024 | themarketherald.com.au | Bianca Gimondo

    Little Green Pharma (ASX:LGP) receives a $5 million R&D rebate, its largest to dateIt reflects the significant R&D expenditure invested in its multifaceted program during FY2023The rebate is in addition to the $360,000 R&D rebate received by subsidiary Rest Mind Sciences in the December quarterLGP shares are up 12 per cent, trading at 14 cents at 11:25 am AEDTLittle Green Pharma (ASX:LGP) has received a $5 million research and development (R&D) rebate, its largest to date.

  • Jan 30, 2024 | themarketherald.com.au | Bianca Gimondo

    Little Green Pharma (ASX:LGP) releases its quarterly activities report for December 2023, reporting a 25 per cent increase in revenue to $18.1 million Revenue for the quarter was $5.4 million and cash receipts amounted to $5.3 million, with year-to-date receipts up 33 per cent to $18.8 million The company’s Cherry Co brand was launched and one of its products, Little Buddies, has become one of its best-performing flower products Reset Mind Sciences launches a psilocybin clinical trial and has...

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →